leisure time -WSS

leisure time

author：leisure time 2025-09-04 22:03:00 - browse：47

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Melinda French Gates resigns from Gates Foundation

explore

WSS

UnitedHealth financials solid despite Change Healthcare cyberattack

Laying a path for careers in science

NEJM study measures Covid brain fog, impact on IQ

Pfizer is about to make a big push in cancer. Will investors listen?

Redefining sustainability for the pharmaceutical industry

Close Medicare's dangerous gaps in addiction treatment coverage

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Medical bills so high, Medicare adding extra digits to claim forms

Anesthesiologist group: stop taking Ozempic before surgery

Cholera vaccine supplies dangerously low, outbreaks surging

Dobbs anniversary: the lost opportunity of abortion as health care

MultiPlan and major insurers sued for alleged medical price

Sports medicine is finally prioritizing gender equality

Elisabeth Bik tackles the widespread issue of research misconduct

Malaria cases in Florida and Texas: Here’s what you need to know

Elisabeth Bik tackles the widespread issue of research misconduct

leisure time

'Vaccine

Cue Health's Covid

Q&A: Jennifer Adair on making gene therapy available globally

Key Senate committee drafts bipartisan bill to stem drug shortages

More tobacco lobbyists active in statehouses

Bird flu outbreak in cows is latest avian flu curveball

explore

hotspot

entertainment

hotspot